Blood Culture Tests Market by Products (Consumables [Bacterial Infections, Mycobacterial Infections, Fungal Infections, Blood Culture Media {Anaerobic Blood Culture Media, Aerobic Blood Culture Media, Fungi/yeast Blood Culture Media, and Others}, Assay Kits & Reagents, and Blood culture accessories], Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory equipment {Incubators, Colony Counter, Microscopes, and Gram Strainers}, and Automated Blood Culture Systems], and Software & Services [Bacterial Infections, Fungal Infections, and Mycobacterial Infections]), Techniques (Conventional and Automated), Technology (Culture-based Technology, Molecular Technology [PCR, Microarray, and PNA-FISH], and Proteomic Technology), Applications (Bacterial Infections, Fungal Infections, and Mycobacterial Infections), End-users (Hospital Laboratories, Reference Laboratories, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa)
Blood Culture Tests Market Outlook
The global blood culture tests market size was valued at USD 4.81 Billion in 2022 and is likely reach to USD 9.62 Billion by 2031, expanding at a CAGR of 8% during the forecast period, 2023–2031. The growth of the market is attributed to factors such as growing number of sepsis cases, increasing frequency of bloodstream infections (BSI), and rapid approvals of new products for BSI diagnosis.
Moreover, increasing aging population and advanced demand for rapid diagnostic techniques present key drivers for the market growth. Blood culture tests includes a range of screening processes that are mainly used to detect the presence of fungi or bacteria in the blood.
These tests help to identify infection in the blood so that the required treatment can be offered to the patient. Identifying blood infection also called as septicemia, is an important medical process since the infection can cause serious problems to the patient such as sepsis.
The initial bacterial infection shows moderate symptoms as high fever, tachycardia, chills, muscular pain, nausea, palpitations, breathlessness, and headache. Without early treatment of these symptoms can result in fatal sepsis indications in the later stage including mottled skin, confusion, dehydration, dizziness, inflammation, drop in blood pressure, and organ failure.
According to World Health Organization (WHO), in 2017, about 49 million cases of sepsis were recorded worldwide and 11 million deaths due to sepsis accounting for approximately 20% of all-cause deaths globally. Nearly 41%, which was approximately 20 million of all global sepsis cases in 2017 were occurred among children under five years of age.
As per a study by the US Centers for Disease Control and Prevention (CDC), central line-associated bloodstream infections (CLABSIs) cause thousands of deaths each year and millions of dollars expenditure incurred to the US healthcare system. Additionally, the data published by Global Health Observatory (GHO) showed that more than 400 million cases of bacterial meningitis were recorded in 26 countries.
Meanwhile, the outbreak of COVID-19 pandemic has affected the market as the pharmaceutical companies and medical device manufacturers have shifted their focus on the development of coronavirus diagnostic kits. It has disturbed the global supply chain of the blood culture testing devices due to delay in the production and shrinking of many laboratory units.
Market Trends, Drivers, Restraints, and Opportunities
- High prevalence of blood stream infections, kidney disorders, sepsis, and other chronic infections as well as accelerated demand for rapid diagnostic tests are huge boosters to the market.
- Technological improvements such as reliability in disease diagnosis, better accuracy, and avoiding unnecessary healthcare costs are expected to fast track the market demand during the forecast period.
- Growing funds in the research and development programs to development of novel products along with increasing private and public healthcare expenditure are expected to drive the global blood culture tests market.
- High cost of equipment and lack of professionals handling the testing devices and procedures are some major restricting factors to the market.
- Several concerns regarding clinical trial outcomes, which include uncertainty, long, and expensive process are projected to hamper the market expansion.
- Technology advancement to develop better equipment, software, and consumables diagnostic kits for the detection of infections in blood are anticipated to offer lucrative opportunities for the market growth.
Scope of Blood Culture Tests Market Report
The report on the global blood culture tests market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Blood Culture Tests Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Products (Consumables [Bacterial Infections, Mycobacterial Infections, Fungal Infections, Blood Culture Media {Anaerobic Blood Culture Media, Aerobic Blood Culture Media, Fungi/yeast Blood Culture Media, and Others}, Assay Kits & Reagents, and Blood culture accessories], Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory equipment {Incubators, Colony Counter, Microscopes, and Gram Strainers}, and Automated Blood Culture Systems], and Software & Services [Bacterial Infections, Fungal Infections, and Mycobacterial Infections]), Techniques (Conventional and Automated), Technology (Culture-based Technology, Molecular Technology [PCR, Microarray, and PNA-FISH], and Proteomic Technology), Applications (Bacterial Infections, Fungal Infections, and Mycobacterial Infections), and End-users (Hospital Laboratories, Reference Laboratories, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Axiom Laboratories; Becton, Dickinson and Co.; Thermo Fisher Scientific, Inc.; Meditech Technologies India Private Limited; bioMérieux SA; Nikon Corp.; Luminex Corp.; Danaher Corp.; Bruker Corp.; IRIDICA; T2 Biosystems, Inc.; Roche Diagnostics; Anaerobe Systems, Inc.; OpGen, Inc.; Carl Zeiss AG; BINDER GmbH; Biobase Biotech (Jinan) Co., Ltd.; Scenker Biological Technology Co., Ltd.; Bulldog Bio, Inc.; and HiMedia Laboratories Pvt. Ltd. |
Blood Culture Tests Market Segment Insights
Consumables segment is expected to grow at a rapid pace
Based on products, the global blood culture tests market is divided into consumables, instruments, and software & services. The consumables segment is further categorized as bacterial infections, mycobacterial infections, fungal infections, assay kits & reagents, blood culture media, and blood culture accessories. The blood culture media is sub-divided into anaerobic blood culture media, fungi/yeast blood culture media, aerobic blood culture media, and others.
The instruments segment is further classified as bacterial infections, fungal infections, mycobacterial infections, laboratory equipment, and automated blood culture systems. Furthermore, the laboratory equipment segment is divided into incubators, colony counter, microscopes, and gram strainers. The software & services is categorized as mycobacterial infections, bacterial infections, and fungal infections.
The consumables segment is expected to grow at a rapid pace during the forecast period owing to rising application of products such as assay, kits, and reagents, and blood culture media for diagnosis. Meanwhile, the instrument segment is anticipated to show considerable growth during the forecast period due to rapid development in diagnostic kits and increasing demand for advanced equipment.
Some of these major instruments such as microscopes, automated systems, colony counters, incubators, and gram strainers are extensively utilized by hospitals and diagnostic laboratories.
Conventional techniques segment is projected to expand at a considerable CAGR
On the basis of techniques, the market is bifurcated into conventional and automated. The conventional segment is projected to expand at a considerable CAGR during the forecast period due to wide adoption of the technique by independent clinical laboratories, hospitals, and pathology laboratories.
However, the automated technique segment is anticipated to hold a key share during the forecast period owing to the rising funding on R&D and technological advancements for precise results.
Culture-based technology segment is anticipated to register a substantial growth rate
Based on technology, the global blood culture tests market is classified into culture-based technology, molecular technology, and proteomic technology. The molecular technology segment is further divided into PCR, microarray, and PNA-FISH.
Due to wide usage of culture-based technology by laboratories, hospital, pathology, and physician office laboratories, the culture-based technology segment grabbed a major market share in 2020 and is anticipated to register a substantial growth rate.
The molecular technology segment, however, is projected to increase its market share at a prominent pace during the forecast period due to the rise in prevalence of infectious disease and funding for the R&D by the manufactures. Owing to its benefits such as reduced test time, higher accuracy, and higher specificity in tests, the PNA-FISH technology sub-segment is estimated to show the highest growth in the near future.
Bacterial infection segment is expected to grow at a substantial CAGR
On the basis of applications, the market is divided into fungal infections, bacterial infections, and mycobacterial infections. The bacterial infection segment is expected to grow at a substantial CAGR during the forecast period due to wide prevalence of bacterial infection and rising demand for screening process to diagnose the disease.
Meanwhile, the fungal infections segment is estimated to exhibit healthy growth during the forecast period due to the growing number of sepsis cases around the globe.
Hospital laboratories segment is projected to constitute a large market share
On the basis of end-users, the global blood culture tests market is segmented into hospital laboratories, reference laboratories, and others. The hospital laboratories segment is projected to constitute a large market share during the forecast period owing to the increasing awareness in the population and government’s initiative for the prevention of infectious diseases and rising visit to hospitals for the diagnosis.
For example, the Centers for Disease Control and Prevention (CDC) cooperated with the government of South Africa to support HIV and TB programs, improve national HIV clinical and research guidelines, and conduct epidemiology training in hospitals.
However, the reference laboratories segment is anticipated to expand at a rapid pace during the forecast period due to the outsourcing of blood culture tests by hospitals to reference laboratories.
Blood Culture Tests Market Regional Outlook
North America is anticipated to dominate the market
In terms of regions, the global market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.
North America is expected to dominate the market in the coming years owing to better healthcare infrastructure, availability of skilled professionals, and presence of big globally leading healthcare companies such as Thermo Fisher Scientific, Inc.; bioMérieux SA; Becton, Dickinson and Company; and Roche Diagnostics.
Meanwhile, Europe is anticipated to expand at a rapid pace during the forecast period owing to the facts of advanced infrastructure and advanced diagnostic products. The market of Asia Pacific, However, is anticipated to exhibit a high CAGR during the projected period due to increasing incidence of the infectious diseases, high population, and rising government interests on the healthcare development.
The growing healthcare investment from emerging economies as well as large population countries such as India and China have several potential for the market expansion in the region. The key reasons for the regional market growth is attributed to prevailing cases of infection diseases, rising geriatric population, increasing approvals and launches of new testing products, and growing healthcare expenditure.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Blood Culture Tests Market Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Blood Culture Tests Market Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Blood Culture Tests Market Market - Supply Chain
4.5. Global Blood Culture Tests Market Market Forecast
4.5.1. Blood Culture Tests Market Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Blood Culture Tests Market Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Blood Culture Tests Market Market Absolute $ Opportunity
5. Global Blood Culture Tests Market Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Blood Culture Tests Market Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Blood Culture Tests Market Demand Share Forecast, 2019-2026
6. North America Blood Culture Tests Market Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Blood Culture Tests Market Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Blood Culture Tests Market Demand Share Forecast, 2019-2026
7. Latin America Blood Culture Tests Market Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Blood Culture Tests Market Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Blood Culture Tests Market Demand Share Forecast, 2019-2026
8. Europe Blood Culture Tests Market Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Blood Culture Tests Market Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Blood Culture Tests Market Demand Share Forecast, 2019-2026
9. Asia Pacific Blood Culture Tests Market Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Blood Culture Tests Market Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Blood Culture Tests Market Demand Share Forecast, 2019-2026
10. Middle East & Africa Blood Culture Tests Market Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Blood Culture Tests Market Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Blood Culture Tests Market Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Blood Culture Tests Market Market: Market Share Analysis
11.2. Blood Culture Tests Market Distributors and Customers
11.3. Blood Culture Tests Market Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Axiom Laboratories Becton, Dickinson and Company Thermo Fisher Scientific, Inc. Meditech Technologies India Private Limited bioMérieux SA Nikon Corp.